BILICKI DANIEL S 4
4 · NANOPHASE TECHNOLOGIES CORPORATION · Filed Nov 20, 2003
Insider Transaction Report
Form 4
BILICKI DANIEL S
VP - Sales & Marketing
Transactions
- Exercise/Conversion
Common Stock
2003-11-19$2.38/sh+18,700$44,413→ 18,700 total - Sale
Common Stock
2003-11-19$5.08/sh−18,700$94,985→ 0 total - Sale
Common Stock
2003-11-18$5.26/sh−38,000$199,869→ 0 total - Exercise/Conversion
Common Stock
2003-11-19$1.75/sh+12,000$21,000→ 12,000 total - Exercise/Conversion
Common Stock
2003-11-18$1.75/sh+38,000$66,500→ 38,000 total - Sale
Common Stock
2003-11-19$5.01/sh−12,000$60,150→ 0 total
Holdings
- 21,000
Stock Option (right to buy)
Exercise: $3.66From: 2004-03-24Exp: 2013-03-24→ Common Stock (21,000 underlying) - 50,000
Stock Option (right to buy)
Exercise: $7.69From: 2001-05-24Exp: 2010-05-24→ Common Stock (50,000 underlying) - 0
Stock Option (right to buy)
Exercise: $1.75From: 2000-07-27Exp: 2009-07-27→ Common Stock (50,000 underlying) - 31,300
Stock Option (right to buy)
Exercise: $2.38From: 2000-03-15Exp: 2009-03-15→ Common Stock (50,000 underlying) - 5,000
Common Stock
- 30,000
Stock Option (right to buy)
Exercise: $10.88From: 2002-01-26Exp: 2011-01-26→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]Subject to certain restrictions, beginning on this date, options vest in five equal annual installments.
- [F2]Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.